[Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness].

Zhonghua Xue Ye Xue Za Zhi

National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.

Published: January 2025

This study retrospectively analyzed the clinical characteristics of patients newly diagnosed with acute myeloid leukemia (AML) who were admitted to the hematology intensive care unit (HCU) with critical illness. It also examined factors associated with critical illness and early mortality in these patients. Clinical data were collected from 91 newly diagnosed AML patients admitted to the HCU of the Department of Hematology, First Affiliated Hospital of Soochow University, from October 2020 to 2024. Reasons for HCU admission, major therapeutic interventions, and risk factors for critical illness and early mortality were analyzed. The median time from diagnosis to HCU admission was 3 days (: 3-9 days), and the median HCU stay was 10 days (: 3-23 days). Of the 91 patients, 71 were admitted to the HCU before induction chemotherapy, while 20 were transferred to the HCU after its initiation. The leading causes of HCU admission were pulmonary infection (78.0% ), respiratory failure (44.0% ), hepatic insufficiency (28.6% ), renal insufficiency (27.5% ), disseminated intravascular coagulation (DIC; 25.3% ), and sepsis (23.1% ). Median Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) and SOFA scores at HCU admission were 14 (: 11-18) and the median Sepsis Related Organ Failure Assessment (SOFA) score was 7 (: 4, 10). Major HCU interventions included vasoactive drugs, noninvasive and invasive mechanical ventilation, continuous renal replacement therapy, therapeutic leukocyte clearance, and cardiopulmonary resuscitation. Among patients receiving induction chemotherapy, the composite complete remission rate was 65.4%, and the overall remission rate was 88.5%. Thirty-five (38.5% ) patients died within 28 days of HCU admission. Independent risk factors for 28-day mortality were DIC (=9.350, 95% 1.999-43.745, =0.005), sepsis (=6.817, 95% 1.571-29.582, =0.010), and cardiac insufficiency (=12.281, 95% 2.385-63.254, =0.003) . The main reason for HCU admission in newly diagnosed critically ill AML patients was pulmonary infection. Nearly 40% of patients experisenced early death, and DIC, sepsis, and heart failure were factors influencing early mortatlity.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn121090-20241211-00561DOI Listing

Publication Analysis

Top Keywords

hcu admission
24
newly diagnosed
16
hcu
12
critical illness
12
diagnosed acute
8
acute myeloid
8
myeloid leukemia
8
patients
8
illness early
8
early mortality
8

Similar Publications

To identify the clinical characteristics and prognosis of patients with hematological disease and neutropenic sepsis in the hematological intensive care unit (HCU). A retrospective analysis was conducted on patients with hematological disease and sepsis who admitted to HCU, the First Affiliated Hospital of Harbin Medical University from October 2017 to October 2024, to examine the primary therapeutic options, prognosis, cause of death, and infectious features of sepsis. A total of 245 septic patients were included in the study, comprising 88 cases in the neutropenic sepsis group (neutropenic group) and 157 cases in the non-neutropenic sepsis group (non-neutropenic group).

View Article and Find Full Text PDF

[Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness].

Zhonghua Xue Ye Xue Za Zhi

January 2025

National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.

This study retrospectively analyzed the clinical characteristics of patients newly diagnosed with acute myeloid leukemia (AML) who were admitted to the hematology intensive care unit (HCU) with critical illness. It also examined factors associated with critical illness and early mortality in these patients. Clinical data were collected from 91 newly diagnosed AML patients admitted to the HCU of the Department of Hematology, First Affiliated Hospital of Soochow University, from October 2020 to 2024.

View Article and Find Full Text PDF

[The value of sequential organ failure assessment and its dynamic changes in predicting mortality in hematology intensive care unit].

Zhonghua Xue Ye Xue Za Zhi

January 2025

State Key Laboratory of Blood and Health, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.

To investigate the value of Sequential Organ Failure (SOFA) score and its dynamics (ΔSOFA) in predicting mortality in hematology care unit (HCU) . A retrospective clinical study was conducted on 79 critically ill hematologic patients admitted to the Center for Critical Care Medicine, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, between May and June 2024. SOFA scores and ΔSOFA were calculated within 2 days before and after HCU admission.

View Article and Find Full Text PDF

Recently, survival rates for patients with hematological malignancies (HMs) have improved, but severe complications have also risen accordingly, and can escalate quickly. Establishing a hematology intensive care unit (HCU) is crucial for early detection and centralized monitoring of critically ill hematological patients, as well as the enhancement of diagnosis, treatment and prognosis and minimizing medical disputes. Based on the guidelines of intensive care unit and hematology department, combined with clinical operation experience of domestic HCU, this consensus is participated by several leading hematology centers in China.

View Article and Find Full Text PDF

Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study.

J Rheumatol

March 2025

Claire Bombardier, MD, UHN, Toronto General Hospital Research Institute, Toronto, Canada; Institute of Health Policy, Management, and Evaluation (IHPME), University of Toronto, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, Canada.

Objective: Rheumatoid arthritis (RA) patients have an increased risk of developing herpes zoster (HZ) compared to the general population. We aimed to measure health care utilization (HCU) and related costs of HZ from the public payer's perspective among RA patients.

Methods: Adult RA patients diagnosed with HZ between 2008 and 2020 were matched (sex, age, and HZ date) to: 1) RA patients without HZ, 2) non-RA population with HZ, and 3) non-RA population without HZ.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!